2025 Not-So-Rosy Predictions On Economy And Healthcare
It’s time to offer up some predictions for 2025. Spoiler alert, they’re not particularly positive expectations, for the economy or
All posts by Joshua P. Cohen
Read More »
Joshua P. Cohen
11:24
Promising Schizophrenia Drug, Cobenfy, Will Face Access Challenges
Cobenfy (xanomeline/trospium chloride; formerly KarXT) was approved for schizophrenia in adults by the Food and Drug Administration in late September.
